Meditherapy announced that it has received KRW 26,000,000,000 in a round of funding on April 9, 2024. The transaction included participation from new investors Company K Partners Limited, Korea Investment Partners Co. Ltd. and DSC Investment Inc.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
7,010 KRW | +4.16% | -0.43% | +5.10% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
7,010 KRW | +4.16% | -0.43% | 77.24M | ||
3,820 KRW | +4.51% | +0.26% | 71.16M | ||
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.10% | 77.24M | |
+17.82% | 3.11B | |
+12.82% | 1.77B | |
+8.43% | 1.52B | |
-11.54% | 1.2B | |
+15.63% | 796M | |
+10.34% | 669M | |
+32.49% | 567M | |
-4.17% | 505M | |
+46.43% | 482M |
- Stock Market
- Equities
- A307930 Stock
- News Company K Partners Limited
- Meditherapy announced that it has received KRW 26 billion in funding from Company K Partners Limited, Korea Investment Partners Co. Ltd., DSC Investment Inc.